-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TzzlZ6RtlgN06ga2Hy2hFjlea5561Rjamcn/z6cvTFFO6iDGKZzjfPwKxns9ecgf xiRec18/vs7Z7ayTpqPsSA== 0000886163-07-000082.txt : 20070601 0000886163-07-000082.hdr.sgml : 20070601 20070601141702 ACCESSION NUMBER: 0000886163-07-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070530 FILED AS OF DATE: 20070601 DATE AS OF CHANGE: 20070601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 BUSINESS PHONE: 8585507500 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aryeh Jason CENTRAL INDEX KEY: 0001376960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 07893676 BUSINESS ADDRESS: BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-05-30 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001376960 Aryeh Jason 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 1 0 0 0 Common Stock 2007-05-30 4 P 0 5000 6.48 A 29700 D Common Stock 2007-05-30 4 P 0 3350 6.48 A 12150 I by Trust Common Stock 1572668 I Indirect Common Stock 25350 I by Spouse All securities disclosed in this Form 3 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds. By: Barbara J. Olson For: Jason Aryeh 2007-06-01 -----END PRIVACY-ENHANCED MESSAGE-----